Holdings derived from the most recent reported transactions. Not adjusted for stock splits or share-class conversions.
| Issuer | Shares | Source | Last tx | Detail |
|---|---|---|---|---|
| SUPERNUS PHARMACEUTICALS, INC. | 958,220 | reported | 13 Mar 2026 | tx 246+6,965,638−3,071,903 |
| TESARO, Inc. | 444,124 | reported | 29 Mar 2016 | tx 2+7,000−7,000 |
| COGNITION THERAPEUTICS INC | 48,500 | reported | 18 Jun 2025 | tx 7+79,670 |
| scPharmaceuticals Inc. | 0 | reported | 07 Oct 2025 | tx 14+123,022−77,174 |
| Date | Type | Issuer | Qty | Price | Signals |
|---|---|---|---|---|---|
| 13 Mar 2026 | SALE | SUPERNUS PHARMACEUTICALS, INC. | 120 | 51.75 USD | |
| 13 Mar 2026 | SALE | SUPERNUS PHARMACEUTICALS, INC. | 10,742 | 51.00 USD | |
| 13 Mar 2026 | OTHER | SUPERNUS PHARMACEUTICALS, INC. | 12,500 | — | |
| 13 Mar 2026 | OTHER | SUPERNUS PHARMACEUTICALS, INC. | 12,500 | — | |
| 13 Mar 2026 | SALE | SUPERNUS PHARMACEUTICALS, INC. | 24,138 | 50.09 USD | |
| 06 Mar 2026 | EXERCISE | SUPERNUS PHARMACEUTICALS, INC. | 38,640 | 0.00 USD | |
| 06 Mar 2026 | TAX_WITHHOLDING | SUPERNUS PHARMACEUTICALS, INC. | 16,574 | 54.73 USD | |
| 06 Mar 2026 | EXERCISE | SUPERNUS PHARMACEUTICALS, INC. | 38,640 | 0.00 USD | deriv |
| 28 Feb 2026 | GRANT_AWARD | SUPERNUS PHARMACEUTICALS, INC. | 38,640 | 0.00 USD | deriv |
| 18 Feb 2026 | GRANT_AWARD | SUPERNUS PHARMACEUTICALS, INC. | 341,610 | 0.00 USD | deriv |
| 09 Oct 2025 | EXERCISE | SUPERNUS PHARMACEUTICALS, INC. | 81,250 | 25.30 USD | |
| 09 Oct 2025 | SALE | SUPERNUS PHARMACEUTICALS, INC. | 58,371 | 50.55 USD | |
| 09 Oct 2025 | SALE | SUPERNUS PHARMACEUTICALS, INC. | 1,529 | 51.46 USD | |
| 09 Oct 2025 | EXERCISE | SUPERNUS PHARMACEUTICALS, INC. | 81,250 | 0.00 USD | deriv |
| 07 Oct 2025 | TENDER | scPharmaceuticals Inc. | 5,000 | — | |
| 07 Oct 2025 | OTHER | scPharmaceuticals Inc. | 19,750 | 0.00 USD | deriv |
| 07 Oct 2025 | OTHER | scPharmaceuticals Inc. | 16,300 | 0.00 USD | deriv |
| 07 Oct 2025 | OTHER | scPharmaceuticals Inc. | 6,124 | 0.00 USD | deriv |
| 07 Oct 2025 | OTHER | scPharmaceuticals Inc. | 30,000 | 0.00 USD | deriv |
| 02 Oct 2025 | EXERCISE | SUPERNUS PHARMACEUTICALS, INC. | 2,267 | 25.30 USD | |
| 02 Oct 2025 | SALE | SUPERNUS PHARMACEUTICALS, INC. | 1,904 | 48.06 USD | |
| 02 Oct 2025 | EXERCISE | SUPERNUS PHARMACEUTICALS, INC. | 2,267 | 0.00 USD | deriv |
| 02 Oct 2025 | EXERCISE | SUPERNUS PHARMACEUTICALS, INC. | 19,320 | 0.00 USD | |
| 02 Oct 2025 | TAX_WITHHOLDING | SUPERNUS PHARMACEUTICALS, INC. | 7,529 | 46.21 USD | |
| 02 Oct 2025 | TAX_WITHHOLDING | SUPERNUS PHARMACEUTICALS, INC. | 7,796 | 46.21 USD |
2 purchases reported after at least 12 months of silence — most recent on 03 Dec 2021.